Yongqiang Ai Selected Research

schizandrol B

1/2021	Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice.
1/2021	The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongqiang Ai Research Topics

Disease

4	Inflammation (Inflammations) 01/2021 - 01/2020
2	Fibrosis (Cirrhosis) 01/2021 - 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 04/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Endotoxemia 01/2020

Drug/Important Bio-Agent (IBA)

3	InflammasomesIBA 04/2020 - 01/2020
2	schizandrol BIBA 01/2021 - 01/2021
2	wedelolactoneIBA 01/2021 - 01/2021
1	liuweiwulingIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Extracellular Matrix ProteinsIBA 01/2021
1	Pharmaceutical PreparationsIBA 04/2020
1	LipopolysaccharidesIBA 04/2020
1	glaucocalyxin AIBA 04/2020
1	carnosolIBA 01/2020
1	dehydrocostus lactoneIBA 01/2020
1	InterleukinsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Therapeutic UsesIBA 01/2020

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2021